penile arterial endothelium has a lower glutathione level HBOT for Erectile Dysfunction: Does It Work? Frontiers | Advances in immune-inflammatory

Description

N Engl J Med 318:1557-1563, 1988

The era of mutation-specific therapies truly started with the FDA and EMA approval of the CFTR potentiator Ivacaftor in patients bearing at least one copy of G551D or some other class III mutation

Sun X, Kong B, Wang W, Chandran P, Selomulya C, Zhang H, Zhu K, Liu Y, Yang W, Guo C

Montalban-Bravo G, Bose P, Alvarado Y, Daver N, Ravandi F, Borthakur G, Takahashi K, Andreeff M , Cortes JE, DiNardo CD, Jabbour E, Kadia TM, Kornblau SM, Ohanian M, Pierola AA, Huang X, Nogueras-Gonzalez GM, Bodden K, Littles K, Pierce S, Bueso-Ramos CE, Kantarjian H, Garcia-Manero G